ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $78,590,000 | +20.9% | 845,595 | -22.5% | 0.01% | +12.5% |
| Q3 2021 | $65,015,000 | -7.4% | 1,091,772 | +6.1% | 0.01% | 0.0% |
| Q2 2021 | $70,185,000 | +582.2% | 1,029,099 | +594.1% | 0.01% | +700.0% |
| Q1 2021 | $10,288,000 | -6.4% | 148,258 | +3.7% | 0.00% | -50.0% |
| Q4 2020 | $10,989,000 | -11.8% | 143,033 | -13.2% | 0.00% | 0.0% |
| Q3 2020 | $12,456,000 | -10.3% | 164,763 | -25.3% | 0.00% | -33.3% |
| Q2 2020 | $13,887,000 | +9.4% | 220,616 | -27.0% | 0.00% | 0.0% |
| Q1 2020 | $12,695,000 | +70.1% | 302,273 | +83.9% | 0.00% | +200.0% |
| Q4 2019 | $7,464,000 | +26.5% | 164,330 | +27.5% | 0.00% | 0.0% |
| Q3 2019 | $5,900,000 | -15.2% | 128,884 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $6,956,000 | +26.3% | 120,083 | -2.2% | 0.00% | 0.0% |
| Q1 2019 | $5,507,000 | +8.3% | 122,842 | -5.9% | 0.00% | 0.0% |
| Q4 2018 | $5,086,000 | -19.3% | 130,573 | -4.7% | 0.00% | 0.0% |
| Q3 2018 | $6,305,000 | +12.9% | 137,010 | +7.0% | 0.00% | 0.0% |
| Q2 2018 | $5,585,000 | +4.7% | 128,095 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $5,333,000 | -6.2% | 135,020 | -19.4% | 0.00% | 0.0% |
| Q4 2017 | $5,688,000 | -28.7% | 167,450 | -46.4% | 0.00% | -50.0% |
| Q3 2017 | $7,980,000 | +48.9% | 312,318 | -1.7% | 0.00% | +100.0% |
| Q2 2017 | $5,361,000 | – | 317,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |